CONMED Corporation
CNMD
$38.46
-$0.95-2.41%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.41% | -94.16% | -28.54% | -69.37% | 2.07% |
| Total Depreciation and Amortization | 6.29% | 3.52% | 4.10% | 1.19% | 1.86% |
| Total Amortization of Deferred Charges | -3.69% | -11.57% | -1.28% | 2.56% | -11.13% |
| Total Other Non-Cash Items | 80.00% | 152.23% | 1,222.22% | 872.18% | 855.23% |
| Change in Net Operating Assets | 32.91% | 1,664.35% | -218.86% | 105.49% | -520.64% |
| Cash from Operations | 6.92% | 4.85% | -32.73% | 42.63% | -23.15% |
| Capital Expenditure | -26.51% | -51.71% | -59.58% | -85.70% | 16.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -76.01% | -51.71% | -59.58% | -43.93% | 16.79% |
| Total Debt Issued | 24.67% | 16.78% | -1.63% | -34.65% | -16.67% |
| Total Debt Repaid | -11.29% | -15.98% | 7.97% | 24.12% | 15.45% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.23% | -0.42% | -0.45% | -0.44% | -0.46% |
| Other Financing Activities | -25.71% | -25.01% | 21.67% | 71.59% | 29.52% |
| Cash from Financing | 26.83% | -12.09% | 39.83% | -66.91% | 13.10% |
| Foreign Exchange rate Adjustments | 101.52% | -96.90% | 354.78% | 259.65% | -319.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 113.48% | -47.97% | 68.91% | 15.35% | -125.72% |